OXFORD NANOPORE (ONT) – Healthcare
| Price: 129.2p +3.6% | P/E: n/a |
| Market Cap: £1.2bn | Yield: n/a |
The nanopore-sensing technology firm has announced Francis van Parys will succeed Gordon Sanghera as chief executive from the start of March 2026.
Van Parys is currently president and CEO of Radiometer, part of US conglomerate Danaher, and previously held senior roles at Cytiva and GE Healthcare.
Our View
This looks like a shrewd appointment as van Parys has several decades of experience in life science businesses and Danaher is very highly regarded by investors, so we aren’t surprised to see ONT shares move higher on this news.
Read the press release here: https://nanoporetech.com/about/investors
Disclaimer: This content is for information only and is not investment advice. Always do your own research before investing. Click here to see full disclaimer.
